-

Sun Nuclear Announces Landmark Update to Further Advance Radiation Therapy Workflows

SunCHECK Version 5.0 addresses clinical workflow challenges with new treatment plan assessment capabilities, enhanced TPS/OIS integration, expanded QA device control, and worklist-based UI.

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK® software for comprehensive Quality Management in radiation therapy. The SunCHECK software is used globally by radiation therapy departments to manage delivery system oversight and patient-specific treatment quality --- all in one platform. SunCHECK Version 5.0 introduces a broad range of features and user-driven enhancements that optimize workflows and prioritize patient safety.

The Connected Workspace for Higher Quality

Toward a vision of a truly connected ecosystem for quality assurance in radiation therapy, key enhancements in SunCHECK v5.0 include:

  • Better, earlier understanding of treatment plan quality and departmental standards from new plan feasibility evaluation and plan complexity metric features
  • Stronger continuity of clinical goals and data management when moving from linac treatment planning system (TPS)/oncology information system (OIS) into the SunCHECK software
  • Automation of time-intensive machine quality measurements with expanded device integration with the PC Electrometer™ device and 1D SCANNER™ water tank
  • At-a-glance worklists and intuitive patient and machine workflows reflected in the refreshed user interface

“In each new release of SunCHECK, we are connecting and accelerating clinical workflows, while expanding compatibility so clinicians can work effectively — regardless of their department structure or equipment. By delivering efficiency gains and easing access to critical insights on treatment quality, we can help clinicians better focus on advancing care,” said Luis Rivera, Sun Nuclear Radiation Therapy President.

Demonstrations of the latest software will be available in the Sun Nuclear booth (#930) at the ESTRO Annual Meeting, May 3-7, in Glasgow, Scotland. Sun Nuclear will host a lunch symposium, with a welcome from Tom Logan, Mirion CEO, on Sunday, May 5.

"I’m pleased to join my Sun Nuclear colleagues at ESTRO as we debut this landmark evolution of the SunCHECK software. This upcoming release is a significant leap forward, offering high impact functionality to support healthcare providers in delivering optimal care to patients,” said Tom Logan, CEO of Mirion.

Learn more about the SunCHECK platform here.

About Sun Nuclear

Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion. We provide innovative solutions for Radiation Therapy and Diagnostic Imaging centers. More than 5,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. Visit us: sunnuclear.com. Follow us: @sunnuclear.

Sun Nuclear, SunCHECK, 1D SCANNER, and PC Electrometer are trademarks or registered trademarks of Mirion Technologies, Inc. and/or its affiliates in the United States and/or other countries.

Contacts

For investor inquiries:
Jerry Estes
ir@mirion.com

For media inquiries:
Erin Schesny
media@mirion.com

Sun Nuclear



Contacts

For investor inquiries:
Jerry Estes
ir@mirion.com

For media inquiries:
Erin Schesny
media@mirion.com

More News From Sun Nuclear

Sun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technical experts and clinical partners for interoperability with the company's new radiotherapy system, Accela. Unveiled at the annual ASTRO conference, Accela is the first software-driven delivery system engineered for NeoArc (Dynamic Modulated Arc Therapy, DMAT), a new treatment technique that accelerates how radia...

Sun Nuclear to Unveil New Innovations Aimed at Strengthening Clinical Confidence at ASTRO 2026

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, will bring next-generation innovations for next-level confidence to the ASTRO 2026 Annual Meeting, beginning Sunday, September 27, in Boston. At Booth 915, attendees will get a first look at new solutions for radiation therapy quality assurance (QA), alongside dedicated programming on smarter QA workflows and one of oncology's fastest-growing areas: radiopharmaceutical therapy.An Exclusive Look: A New Way to See Machine Hea...

Sun Nuclear to Showcase Next-Generation Innovations at AAPM & COMP 2026 Annual Meeting

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, announced today the featured innovations in quality assurance (QA) for machine oversight and adaptive radiotherapy, as well as AI-assisted treatment planning, to be shown at the 2026 AAPM & COMP Annual Meeting, July 19–21 in Vancouver. Centered on the theme of Next-Gen Innovations for Next-Level Physics, the Sun Nuclear exhibit reflects a focus on smart, practical tools that support medical physics teams to operate wit...
Back to Newsroom